Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in renal transplantation between 1990 and 2002 in Spain

Background. Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II type 1 receptor blockers (ARB) decrease cardiovascular mortality and slow the progression of renal disease in non-transplant patients, but their impact on kidney transplant outcome has not been well established. Methods....

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández, Ángel Alonso, Moreso, Francesc, Bayés, Beatriz, Lauzurica, Ricardo, Sánz-Guajardo, Dámaso, Gómez-Huertas, Ernesto, Pereira, Porfirio, Paul, Javier, Crespo, Josep, Amenábar, Juan J., Oliver, Juan, Serón, Daniel
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875045/
https://www.ncbi.nlm.nih.gov/pubmed/20508862
http://dx.doi.org/10.1093/ndtplus/sfq068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875045/
https://www.ncbi.nlm.nih.gov/pubmed/20508862
http://dx.doi.org/10.1093/ndtplus/sfq068

Ejemplares similares